Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3192

Actual shortage: 254 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2927 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MOMETASONE 0.1% OINTMENT Resolved 2022-02-17 2022-04-21 155149
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2022-05-12 2022-09-08 160445
TEVA-MOMETASONE 0.1% OINTMENT Resolved 2022-08-18 2023-07-21 167209
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2022-09-30 2022-10-29 170764
TEVA-MOMETASONE 0.1% OINTMENT Resolved 2023-06-19 2023-07-05 195472
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Resolved 2024-01-11 2024-08-01 215760
TEVA-MOMETASONE 0.1% OINTMENT Resolved 2024-02-29 2024-12-19 220986
TEVA-MOMETASONE 0.1% OINTMENT Resolved 2024-04-11 2024-10-17 224886
TEVA-MOMETASONE 0.1% OINTMENT Resolved 2024-12-19 2025-03-27 246104
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2025-02-13 2025-12-11 250393
TEVA-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2019-09-05 2019-09-27 93134
TEVA-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2020-03-06 2020-05-14 107992
TEVA-MONTELUKAST 4MG TABLET (CHEWABLE) Resolved 2020-03-26 2020-05-14 109577
TEVA-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2022-06-30 2022-10-18 163951
TEVA-MONTELUKAST 5MG TABLET (CHEWABLE) Actual shortage 2025-12-04 2025-12-04 273302
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110712
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110716
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-09 110719
TEVA-MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-04-23 110722
TEVA-MORPHINE SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110725

Showing 2021 to 2040 of 3192

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2021-02-12 2021-02-12 133886
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2025-05-27 2025-05-27 258359
CEFTRIAXONE SODIUM FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2025-05-28 2025-05-28 258691
CLOXACILLIN SODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14014
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
COUGH SYRUP WITH CODEINE 30MG 3.3MG 100MG SYRUP SYRUP Reversed 2025-05-28 2025-06-03 258600
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337

Showing 81 to 100 of 435